Pansements antimicrobiens

Mepilex Border Ag

Self-adherent antimicrobial soft silicone foam dressing

  • {{ feature }}

  1. Mepilex Border Ag consists of a Safetac® soft silicone wound contact layer, an absorbent polyurethane foam pad containing silver sulphate and coloured by activated carbon, a layer with super absorbent fibres, a nonwoven and a breathable and water proof film. Safetac® is a proprietary adhesive technology developed by Mölnlycke that minimises pain to patients and trauma to intact skin or wounds. Mepilex Border Ag is a soft silicone foam dressing that absorbs exudate, maintains a moist wound healing environment and has antimicrobial properties. Mepilex Border Ag contains silver sulphate to create an effective bacterial barrier and inactivate a wide range of wound related pathogens (bacteria and fungi), as shown in vitro. By reducing the number of microorganisms, Mepilex Border Ag may also reduce odour. Mepilex Border Ag has been shown to inactivate wound related pathogens up to 7 days in vitro.

    1. 01

      Fast (as from 30 min, in vitro), sustained (up to 7 days, in vitro) and broad range antimicrobial action (in vitro)

    2. 02

      Efficient exudate handling by minimising leakage and a high absorption, retention and MVTR. This could help support a reduced number of dressing changes

    1. Mölnlycke Health Care. NAMSA reference 10C_39972_01. (Modified) ISO 20743:2007 Determination of antibacterial activity of antibacterial finished products. Data on file, 2010. Mölnlycke Health Care. NAMSA references 09C_29253_01, 09C_29252_01, 09C_29253_02. ASTM E2149-01 Determining the antimicrobial activity of immobilized antimicrobial agents under dynamic contact conditions. Data on file, 2009. Mölnlycke Health Care. T- 1050 Shake flask method for determination of antimicrobial effect of material and products. Data on file, 2009. Mölnlycke Health Care. T- 1050 Shake flask method for determination of antimicrobial effect of material and products. Data on file, 2009.
    2. Huss, F., Thorfinn, J. An open, non-controlled, postmarketing investigation evaluating the experience of using a self-adherent antimicrobial soft silicone, silver containing, foam dressing, Mepilex Border Ag, in second degree burns. PMCF study MxB Ag 02 from Mölnlycke Health Care. Unpublished data, 2011. Latenser, B., Alvarez, OM., Treadwell, T. Open multicentre investigation to evaluate signs and symptoms of local inflammation/infection on chronic ulcers and partial thickness burns when using Mepilex Border Ag as an anti-microbial wound dressing. PMCF study MxB Ag 01 from Mölnlycke Health Care. Unpublished data, 2012. Kles C.L., Murrah, C.P., Smith, K., Baugus- Wellmeier, E., Hurry, T., Morris, C.D. Achieving and sustaining zero. Preventing surgical site infections after isolated coronary artery bypass with saphenous vein harvest through implementation of a staffdriven quality improvement process. Dimensions of Critical Care Nursing 2015;34(5):265-272.
  2. Packaging level Quantity GTIN code
    {{ row.packagingLevel }} {{ row.quantity }} {{ row.gtinCode }}

    {{ item.key }}: {{ item.value }}